|
Neoplasia
Citations 341-350 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study
- Simone Boehrer, Lionel Adès, Thorsten Braun, Lorenzo Galluzzi, Jennifer Grosjean, Claire Fabre, Génèviève Le Roux, Claude Gardin, Antoine Martin, Stéphane de Botton, Pierre Fenaux, and Guido Kroemer
Blood 2008; 111: 2170-2180.
[Abstract]
[Full text]
[PDF]
IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes
- Michal Marzec, Xiaobin Liu, Monika Kasprzycka, Agnieszka Witkiewicz, Puthiyaveettil N. Raghunath, Mouna El-Salem, Erle Robertson, Niels Odum, and Mariusz A. Wasik
Blood 2008; 111: 2181-2189.
[Abstract]
[Full text]
[PDF]
p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death
- Ondrej Krejci, Mark Wunderlich, Hartmut Geiger, Fu-Sheng Chou, David Schleimer, Michael Jansen, Paul R. Andreassen, and James C. Mulloy
Blood 2008; 111: 2190-2199.
[Abstract]
[Full text]
[PDF]
Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib
- Matthias Mayerhofer, Karoline V. Gleixner, Julia Mayerhofer, Gregor Hoermann, Eva Jaeger, Karl J. Aichberger, Rene G. Ott, Khaled Greish, Hideaki Nakamura, Sophia Derdak, Puchit Samorapoompichit, Winfried F. Pickl, Veronika Sexl, Harald Esterbauer, Ilse Schwarzinger, Christian Sillaber, Hiroshi Maeda, and Peter Valent
Blood 2008; 111: 2200-2210.
[Abstract]
[Full text]
[PDF]
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action
- Zhengxing Qu, David M. Goldenberg, Thomas M. Cardillo, Victoria Shi, Hans J. Hansen, and Chien-Hsing Chang
Blood 2008; 111: 2211-2219.
[Abstract]
[Full text]
[PDF]
Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy
- Yulia Nefedova, Daniel M. Sullivan, Sophia C. Bolick, William S. Dalton, and Dmitry I. Gabrilovich
Blood 2008; 111: 2220-2229.
[Abstract]
[Full text]
[PDF]
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
- Linfeng Chen, Stefano Monti, Przemyslaw Juszczynski, John Daley, Wen Chen, Thomas E. Witzig, Thomas M. Habermann, Jeffery L. Kutok, and Margaret A. Shipp
Blood 2008; 111: 2230-2237.
[Abstract]
[Full text]
[PDF]
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
- Jeffrey W. Tyner, Denise K. Walters, Stephanie G. Willis, Mary Luttropp, Jason Oost, Marc Loriaux, Heidi Erickson, Amie S. Corbin, Thomas O'Hare, Michael C. Heinrich, Michael W. Deininger, and Brian J. Druker
Blood 2008; 111: 2238-2245.
[Abstract]
[Full text]
[PDF]
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia
- Göran Roos, Alexander Kröber, Pawel Grabowski, Dirk Kienle, Andreas Bühler, Hartmut Döhner, Richard Rosenquist, and Stephan Stilgenbauer
Blood 2008; 111: 2246-2252.
[Abstract]
[Full text]
[PDF]
Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?
- Alexandra Traverse-Glehen, Lucile Baseggio, Evelyne Callet- Bauchu, Dominique Morel, Sophie Gazzo, Martine Ffrench, Aurélie Verney, Delphine Rolland, Catherine Thieblemont, Jean-Pierre Magaud, Gilles Salles, Bertrand Coiffier, Françoise Berger, and Pascale Felman
Blood 2008; 111: 2253-2260.
[Abstract]
[Full text]
[PDF]
|
|
